SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-129353
Filing Date
2019-04-30
Accepted
2019-04-30 16:14:04
Documents
5
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d680527ddefa14a.htm DEFA14A 20700
2 GRAPHIC g680527dsp005.jpg GRAPHIC 85152
3 GRAPHIC g680527dsp006.jpg GRAPHIC 154628
4 GRAPHIC g680527dsp007.jpg GRAPHIC 36491
5 GRAPHIC g680527dsp008.jpg GRAPHIC 12032
  Complete submission text file 0001193125-19-129353.txt   390492
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37465 | Film No.: 19781875
SIC: 2834 Pharmaceutical Preparations